Who among MDR patients don't want to save his life rapidly? I am not really an expert in HIV & MDR patients but it seems to me that the pool of 20,000 to 25,000 patients represents people who are sick to the point of dying in the coming months or in the next 1 to 2 years. We are anticipating here sales for the first year, depending on who speaks, between 500 and 10000 patients, with an average of 4000 patients. But why such a low adoption rate? You seem to forget that these people do not have the time to wait and risk dying while waiting. Who among them would be crazy enough not to make a request to their doctor to get the Trogarzo in the first few months when it will be available? Considering this, I can not understand that the rate of adoption of the drug is less than 80% of the pool of eligible patients, in the first 6 to 12 months after the Trogarzo is put on sale ... That would represents 16000+ to 20000+ patients. What that I do not understand?
I am a shareholder of TH since 2001.
And i read this board since 2015.